In-Med Prognostics
PrivateLast Round
Seed
Dec 12, 2022
Total Funding Raised
$2.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
In-Med Prognostics is a healthtech company that provides an AI-driven platform for analyzing medical images to aid in the assessment and early detection of neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
In-Med Prognostics Comparables
Compare In-Med Prognostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brainreader | 85% | |
| Darmiyan | 84% | |
| BrainNow Medical Technology | 82% |
In-Med Prognostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 12, 2022 | ||||
| Accelerator | Apr 15, 2021 | ||||
| Grant | Jan 9, 2019 |
Key People
Founding team and executive leadership
In-Med Prognostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant |
| RICH | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 353% MoM.
- Feb 3, 2026
Monthly visitors grew 105% MoM.
In-Med Prognostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about In-Med Prognostics's valuation, stock price, and market status.
Is In-Med Prognostics a public or private company?
In-Med Prognostics is a private company.
What is the current stock price of In-Med Prognostics?
In-Med Prognostics is a private company with no public stock price. No recent secondary market data is available.
How much is In-Med Prognostics worth (valuation)?
Valuation information for In-Med Prognostics is not publicly available.
Can I buy In-Med Prognostics stock?
In-Med Prognostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was In-Med Prognostics's last funding round?
In-Med Prognostics's most recent funding round was Seed on December 12, 2022.
Who are the main investors in In-Med Prognostics?
Key investors in In-Med Prognostics include Biotechnology Industry Research Assistance Council, RICH.
Will In-Med Prognostics IPO soon?
No public IPO plans have been announced for In-Med Prognostics.
How can I track In-Med Prognostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor In-Med Prognostics's secondary market activity and sign up for updates.